About MeI’m a thoracic oncologist dedicated to advancing the care and treatment of patients with thoracic malignancies – such as adenocarcinoma, mesothelioma and thymic cancers – by helping develop novel therapeutic approaches to these diseases. Such treatments range from combinations of conventional cytotoxic chemotherapy, novel targeted agents and immunotherapy applied to patients with early stage or advanced disease. I was rated in the top 10 percent of physicians in the nation for patient satisfaction in 2017.
I am a professor of internal medicine, associate division director for education in the Division of Medical Oncology, associate program director of the Hematology/Oncology Fellowship Program and clinical director of the Thoracic Oncology Disease Specific Research Group at OSUCCC – James. I serve on the National Comprehensive Cancer Network (NCCN) nonsmall cell lung cancer guidelines panel.
At The James, we have a true multi-disciplinary team in thoracic oncology that includes medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists, pathologists, radiologists, nurses, pharmacists, nurse practitioners and physician assistants. Together we work to continually improve patients’ quality of life and develop effective therapies in an effort to end cancer.
- Named to the Castle Connolly list of America’s “Top Doctors” for 2017
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2017
- Best Doctor in America 2017
Specialties and conditions I treat
- Medical Oncology
- Lung Cancers
- Lung Cancers
- Pleural Cancers
- Thymus Cancers
Locations where I practice
Education and training
Georgetown University School of Medicine
Rush-Presbyterian-St.Luke's Med Ctr
6/30/1987 - 6/30/1989
More about my work
National Cancer Institute
6/30/1989 - 6/30/1992
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Medicine Oncology)
News about me
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/28/2017, Dr. Otterson has reported no financial relationships with medical device, research and/or drug companies.